Get up to date in the areas of Digestive Oncologic Surgery that have experienced the most advances in recent years, including complementary studies and advanced surgical techniques” 

The developments and milestones achieved in the field of Digestive Oncologic Surgery have allowed to raise the standard of care considerably.

Multimodal therapies such as polychemotherapy, highly focused radiotherapy or targeted molecular therapies have greatly expanded the possibilities of action and intervention for specialists, obliging them in turn to an almost continuous process of updating.

Therefore, the necessary criteria must be developed to determine when new technologies can be useful and how they should be used to get the most out of them. Oncologic Digestive Surgery cannot be understood as a linear specialty, but must be covered with a multidisciplinary vision, allowing the surgeon to get involved with radiology, endoscopy or nutrition units in order to obtain a more effective diagnosis and treatment.

Faced with this situation, TECH has brought together a teaching team of renowned experts in advanced surgical techniques to create this Professional master’s degreew. It is not intended to be a compilation of surgical techniques, but to examine the possibilities of current surgery, the specialties that work around it and the new technologies available to specialists to treat tumors of the digestive system. 

Therefore, topics related to the fields of Esophagogastric and Colorectal Oncologic Surgery are included, as well as the latest scientific postulates in Liver Tumors, Liver Metastases, Mesenchymal Tumors and other pathologies in the area of Digestive Oncology. The research aspect is not left aside, dedicating also a space to innovation and development in the field.

It is a great academic opportunity to get up to date in a dynamic and effective way, focusing on clinical practice at the highest level. The format of the program, moreover, is completely online. This means that there are no in person classes or fixed schedules, giving total flexibility to specialists to adapt the teaching load according to their own responsibilities. 

Delve into the management and endoscopic treatment of a variety of pathologies such as esophageal cancer or biliary tract tumors”

This Professional master’s degree in Digestive Oncologic Surgery contains the most complete and up-to-date scientific program on the market. The most important features include:

• The development of practical cases presented by experts in Digestive Surgery and Oncology
• The graphic, schematic and practical contents with which it is conceived provide scientific and practical information on those disciplines that are essential for professional practice
• Practical exercises where the self-assessment process can be carried out to improve learning
• Its special emphasis on innovative methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

You will be able to download all the didactic material to study it later from the comfort of your tablet, smartphone or computer of choice”

The program’s teaching staff includes professionals from the sector who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities.

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the course. For this purpose, students will be assisted by an innovative interactive video system created by renowned and experienced experts.

Get updated in the use of Big Data, Artificial Intelligence and Neural Networks for modern oncology research"

Define your own schedule, as the Virtual Campus is accessible 24 hours a day from any device with Internet connection"

All the contents of this Professional master’s degree have been developed based on the Relearning pedagogical methodology. This implies that the academic experience is more dynamic and effective, since the key concepts in Digestive Oncologic Surgery are reiterated and provided in a natural way throughout the program. In turn, this saves a considerable amount of the study hours required to pass the course.

Access detailed videos, case studies and practical analysis of a host of common and uncommon pathologies in Digestive Oncologic Surgery”

Module 1. Digestive Oncologic Surgery 

1.1. Surgical Anatomy of the Abdomen 

1.1.1. Anatomy of the Abdominal Cavity 
1.1.2. Esophagogastric Anatomy 
1.1.3. Hepatobiliary Anatomy 
1.1.4. Colorectal Anatomy 

1.2. Prehabilitation Multimodal Rehabilitation 

1.2.1. Prehabilitation 
1.2.2. Intraoperative Measures 
1.2.3. Postoperative Measures 

1.3. Fundamentals of Nutrition in Oncological Digestive Surgery 

1.3.1. Determination of Nutritional Status 
1.3.2. Consequences of Malnutrition 
1.3.3. Measures to Improve Preoperative Nutritional Status 

1.4. Anesthesia in Oncologic Digestive Surgery 

1.4.1. Preparation for Anesthesia 
1.4.2. The Importance of Anesthesia in Oncologic Surgery 
1.4.3. Anesthesia in Complex Surgeries 

1.5. Post-Surgical Resuscitation 

1.5.1. Patient Optimization after Surgery 
1.5.2. Detection of Early Complications 
1.5.3. Sepsis and Systemic Inflammatory Response 

1.6. Palliative Surgery in Digestive Oncology 

1.6.1. What is Palliation? 
1.6.2. When do we Talk about Palliation? 
1.6.3. Palliative Surgical Techniques 

1.7. Fundamentals of Emergency Surgery in Digestive Oncology 

1.7.1. Urgent Situations in Oncologic Surgery 
1.7.2. Urgent Esophagogastric Surgery 
1.7.3. Urgent Hepatobiliary Surgery 
1.7.4. Urgent Colorectal Surgery 

1.8. Molecular Basis of Digestive Oncology 
1.9. Interaction Between Systemic Treatments and Surgery 

1.9.1. Mechanism of Action of Systemic Oncologic Treatments 
1.9.2. Interaction and Consequences on Surgery 
1.9.3. Measures to Minimize Related Surgical Complications Systemic Contracting 

1.10. Radiation Oncology in Digestive Oncologic Surgery 

1.10.1. Fundamental Concepts of Radiotherapy 
1.10.2. Principles of Radiotherapy in the Different Organs of the Digestive Tract 
1.10.3. Side Effects of Radiotherapy on the Gastrointestinal Tract Prevention and Treatment 

Module 2. Complementary Studies in Digestive Oncologic Surgery  

2.1. Role of Conventional Radiological Techniques 

2.1.1. Initial Diagnosis 
2.1.2. Extension Study in Patients with Digestive Tumors 
2.1.3. Treatment Plan 

2.2. Role of Conventional Radiology in the Early Diagnosis and Follow-Up of Patients with Digestive Tumors 

2.2.1. Ultrasound 
2.2.2. CAT 
2.2.3. MRI  

2.3. Role of Interventional Radiology in Digestive Tumors 

2.3.1. Diagnostic Techniques 
2.3.2. Participation in Treatment 
2.3.3. Role in the Management of Complications 

2.4. Nuclear Medicine in the Management of Digestive Tumors 

2.4.1. Diagnostic Techniques 
2.4.2. Role in Treatment 
2.4.3. Radioguided Surgery 

2.5. Anatomopathologic Diagnosis Beyond Morphology 

2.5.1. Importance of Intraoperative Biopsy 
2.5.2. Handling of Fresh Specimen and Study of Margins 
2.5.3. Histological Risk Factors 
2.5.4. Standardization of Reports  

2.6. Molecular Diagnoses 

2.6.1. Concept of Molecular Diagnostics 
2.6.2. Cancer Panels 
2.6.3. From Diagnosis to the Design of Personalized Therapies 

2.7. Genetic Study in Patients with Risk Factors for Digestive Tumors 

2.7.1. Hereditary Syndromes Associated with Digestive Tumors 
2.7.2. Detection of Patients at Risk 
2.7.3. Follow-Up and Prophylactic Treatment in Patients at Risk  

2.8. Endoscopy in the Diagnosis and Treatment of Digestive Tumors 

2.8.1. Conventional and Advanced Diagnostic Endoscopy 
2.8.2. Introduction to Endoscopic Techniques for the Treatment of Digestive Tumors 
2.8.3. Endoscopy in Palliative Treatment 

2.9. Microbiome and Digestive Tumors 

2.9.1. Microbiota Concept 
2.9.2. Role of the Microbiome in Carcinogenesis 
2.9.3. Role of the Microbiome in the Early Diagnosis and Prevention of Digestive Tumors 

2.10. Preoperative Assessment of the Elderly Patient 

2.10.1. Surgical Risk Scales 
2.10.2. Concept of Fragility 
2.10.3. Prehabilitation in the Elderly 

Module 3. Colorectal Oncologic Surgery 

3.1. Colorectal Cancer 

3.1.1. Epidemiology and Etiopathogenesis 
3.1.2. Diagnosis and Staging 
3.1.3. Follow-up and Prognosis of Colorectal Adenocarcinoma 

3.2. Polyposis Syndromes 

3.2.1. Diagnosis 
3.2.2. Treatment 
3.2.3. Monitoring 

3.3. Endoscopic Management of Precursor Lesions and Early Cancer 

3.3.1. Biliopancreatic Precursor Lesions 
3.3.2. Early Cancer 
3.3.3. Decisions after Endoscopic Resection 

3.4. Surgical Treatment of Colon Cancer Fundamental Concepts about Ostomies 

3.4.1. Right Colon 
3.4.2. Transverse Colon 
3.4.3. Left Colon 
3.4.4. Colostomies and Ileostomies  

3.5. Surgical Anatomy of the Pelvis 

3.5.1. General Concepts 
3.5.2. Male Pelvis 
3.5.3. Female Pelvis 

3.6. Surgical Treatment of Rectal Cancer 

3.6.1. Early Stages 
3.6.2. Advanced Stages 
3.6.3. Functional Sequelae 

3.7. Medical Oncology in Colorectal Cancer 

3.7.1. Non-Metastatic Colorectal Cancer 
3.7.2. Metastatic Colorectal Cancer 
3.7.3. Palliative Treatment 

3.8. Radiation Oncology in Colorectal Cancer 

3.8.1. Radiotherapy in Rectal Cancer 
3.8.2. Radiotherapy in Pelvic Recurrence 
3.8.3. Radiotherapy in Special Situations 

3.9. Total Neoadjuvant Treatment in Rectal Cancer Watch and Wait 

3.9.1. Concept and Justification of TNT 
3.9.2. Current TNT Schemes 
3.9.3. Watch and Wait Concept, Handling and Indications 

3.10. Surgical Treatment in Special Situations 

3.10.1. Pelvic Recurrence of Rectal Cancer 
3.10.2. Positive Pelvic Adenopathies in Rectal Cancer 
3.10.3. Retroperitoneal Lymph Node Recurrence: Surgery vs. Radiotherapy 

Module 4. Esophagogastric Oncologic Surgery 

4.1. General Aspects from Esophageal Cancer 

4.1.1. Epidemiology and Etiopathogenesis 
4.1.2. Classification and Diagnosis 
4.1.3. Monitoring and Prognosis 

4.2. Surgical Treatment of Esophageal Cancer 

4.2.1. Types of Anastomosis 
4.2.2. Standard and Extended Lymphadenectomy 
4.2.3. Alternatives to Gastric Plasty Reconstruction 

4.3. Endoscopic and Interventional Treatment of Esophageal Cancer 

4.3.1. Treatment of Precursor Lesions 
4.3.2. Treatment of Early Cancer 
4.3.3. Palliative Treatment 
4.3.4. Management of Complications 

4.4. Cancer of the Oesophagogastric Junction 

4.4.1. Controversies in the Management of UEG Cancer 
4.4.2. Approach According to the New Clinical Guidelines 
4.4.3. Lymphadenectomy and Surgical Approach 

4.5. General Aspects of Gastric Cancer 

4.5.1. Epidemiology and Etiopathogenesis 
4.5.2. Classification and Diagnosis 
4.5.3. Monitoring and Prognosis 

4.6. Surgical Treatment of Gastric Cancer 

4.6.1. Anastomosis 
4.6.2. Technical Basis of Lymphadenectomy 
4.6.3. Treatment of Non-Adenocarcinoma Tumors 
4.6.4. Endoscopic Treatment 

4.7. Oncologic Therapies for Esophagogastric Tumors 

4.7.1. Neoadjuvant and Adjuvant Chemotherapy 
4.7.2. Neoadjuvant and Adjuvant Radiotherapy 
4.7.3. New Oncological Therapies: Immunotherapy 

4.8. Oncologic Esophagogastric Surgery Complications 

4.8.1. Immediate Postoperative Complications 
4.8.2. Post Gastrectomy Sequelae 
4.8.3. Post-Thesophagectomy Sequelae 

4.9. Intensified Recovery in Esophagogastric Surgery 

4.9.1. Prehabilitation 
4.9.2. Optimization 
4.9.3. Clinical Pathway 

4.10. Research and Innovation in Esophagogastric Oncologic Surgery 

Module 5. Liver and Biliary Tract I. General. Liver Tumors 

5.1. Surgical Anatomy of the Liver 

5.1.1. Hepatic Segmentation 
5.1.2. Hepatic Vascular Distribution 
5.1.3. Anatomy of the Biliary Tract 

5.2. Diagnostic Tests in Hepatobiliary Pathology 

5.2.1. Ultrasound 
5.2.2. CAT 
5.2.3. MRI 

5.3. Assessment of Residual Liver Volume and Function 

5.3.1. Concept and Limits of Residual Hepatic Volume 
5.3.2. Techniques for Measuring RHV 
5.3.3. Methods of Liver Function Determination 

5.4. Principles of Liver Surgery 

5.4.1. Fundamental Aspects and Phases of Hepatic Resection 
5.4.2. Parenchymal Section Techniques 
5.4.3. Pringle's Maneuver and Vascular Control 
5.4.4. Hemostasis and Bilistasis 

5.5. Techniques to Increase Hepatic Resectability 

5.5.1. Hepatic Regeneration 
5.5.2. Portal Embolization and 2-Stage Surgery 
5.5.3. ALPPS Technique 

5.6. Minimally Invasive Hepatic Surgery: Laparoscopy and Robotics 

5.6.1. Basis of Minimally Invasive Surgery in Hepatobiliary Surgery 
5.6.2. Laparoscopic Approach 
5.6.3. Contribution of the Robotic Approach 

5.7. Complications of Hepatic Surgery and Postoperative Management 

5.7.1. Post-Operative Care ERAS 
5.7.2. Complications of Hepatobiliary Surgery 
5.7.3. Treating Complications 

5.8. Benign and Malign Hepatic Tumors 

5.8.1. Benign Hepatic Tumors 
5.8.2. Malign Hepatic Tumors 
5.8.3. Hepatocellular Carcinoma: Epidemiology, Risk Factors, Classification and Diagnosis 

5.9. Hepatocarcinoma: Non-Surgical Treatment 

5.9.1. Alternative Treatments and "Bridges" to Surgery 
5.9.2. Medical Treatment 

5.10. Hepatocarcinoma: Surgical Treatment 

5.10.1. Study of the Patient with Hepatocarcinoma 
5.10.2. Surgical Resection 
5.10.3. Liver Transplant

Module 6. Liver and Biliary Tract II. Tumors of the Biliary Tract. Liver Metastases 

6.1. General Aspects of Gallbladder and Bile Duct Cancer 

6.1.1. Epidemiology and Etiopathogenesis
6.1.2. Classification 
6.1.3. Diagnosis 

6.2. Surgery of the Bile Duct and Gallbladder Tumors 

6.2.1. Surgery of Intrahepatic BV Tumors 
6.2.2. Surgery of Extrahepatic BV Tumors 
6.2.3. Surgery of Gall Bladder Tumors 

6.3. Endoscopic and Interventional Treatment of Biliary Tract and Gallbladder Tumors 

6.3.1. Preoperative Endoscopic Treatment 
6.3.2. Preoperative Interventional Radiology 
6.3.3. Endoscopic Treatment of Complications 
6.3.4. Interventional Radiology in Complications 

6.4. Medical Oncology Treatment of Biliary Tract and Gallbladder Tumors 

6.4.1. Medical Oncology in Biliary Tract Cancer 
6.4.2. Medical Oncology in Gallbladder Cancer 

6.5. Radiation Oncology Treatment of Biliary Tract and Gallbladder Tumors 

6.5.1. Radiotherapy in Biliary Tract Cancer 
6.5.2. Radiotherapy in Gallbladder Cancer 

6.6. General Aspects of Liver Metastases 

6.6.1. Epidemiology and Etiopathogenesis 
6.6.2. Classification 
6.6.3. Diagnosis and Prognosis 

6.7. Surgical Treatment of Liver Metastases from Colorectal Cancer and Alternatives to Surgical Treatment 

6.7.1. Evaluation and Surgical Planning in Patients with Colorectal Cancer Liver Metastases 
6.7.2. Surgical Alternatives and Transplantation 
6.7.3. Non-Surgical Alternatives 

6.8. Medical Oncology in the Treatment of Liver Metastases from Colorectal Cancer 

6.8.1. Neoadjuvant and Adjuvant Treatment 
6.8.2. Palliative Treatment 
6.8.3. New Perspectives 

6.9. Metastases of Neuroendocrine Tumors 

6.9.1. Classification, Diagnosis and Prognosis 
6.9.2. Surgical Treatment 
6.9.3. Role of Liver Transplantation 

6.10. Hepatic Metastases of other Non-Colorectal Non-Neuroendocrine Tumors 

6.10.1. Metastases of ENT Tumor 
6.10.2. Esophagogastric Tumor Metastases 
6.10.3. Metastasis of Breast Cancer 1 
6.10.4. Metastases of Pancreatic Cancer 

Module 7. Pancreas, Duodenum and Spleen 

7.1. Epidemiological, Risk and Genetic Factors of Pancreatic Cancer 

7.1.1. Epidemiology of Pancreatic Cancer 
7.1.2.  Risk Factors 
7.1.3. Genetics 

7.2. Diagnosis of Pancreatic Cancer 

7.2.1. Radiology 
7.2.2. Endoscopy 
7.2.3. PET-CAT 

7.3. Therapeutic Strategy according to the NCCN Classification of Pancreatic Cancer 

7.3.1. Resectable Tumor 
7.3.2. Borderline Tumor 
7.3.3. Unresectable Tumor 
7.3.4. Metastatic Tumor 

7.4. Surgical Techniques by Laparotomy in Pancreatic Cancer 

7.4.1. Cephalic Duodenopancreatectomy 
7.4.2. Distal Pancreatectomy 
7.4.3. Central Pancreatectomy 

7.5. Minimally Invasive Techniques: Laparoscopic and Robotic in Pancreatic Cancer 

7.5.1. Laparoscopic Duodenopancreatectomy 
7.5.2. Laparoscopic Distal Pancreatectomy 
7.5.3. Robotic Surgery of the Pancreas 

7.6. Palliative Surgical Techniques in Pancreatic Cancer 

7.6.1. Palliation of Jaundice 
7.6.2. Digestive Obstruction 
7.6.3. Pain Control 
7.6.4. Palliative Ablative Techniques 

7.7. Postoperative Complications in Pancreatic Cancer 

7.7.1. Pancreatic Fistula 
7.7.2. Delayed Gastric Emptying 
7.7.3. Postoperative Hemorrhage 
7.7.4. Biliary Fistula 
7.7.5. Other Complications 

7.8. Chemotherapy and Radiotherapy in Pancreatic Cancer 

7.8.1. Neoadjuvant 
7.8.2. Adjuvants 
7.8.3. Palliative Medical Treatment 
7.8.4. Radiotherapy 

7.9. Other Pancreatic Tumors 

7.9.1. Cystic Tumors 
7.9.2. Neuroendocrine Tumors 
7.9.3. Infrequent Tumors of the Pancreas 

7.10. Duodenal and Spleen Tumors 

7.10.1. Duodenal Tumors 
7.10.2. Spleen Tumors 

Module 8. Malignant Peritoneal Disease 

8.1. Principles of Treatment of Malignant Peritoneal Diseases 

8.1.1. Pathophysiology of Peritoneal Dissemination Mechanisms 
8.1.2. Indications for Radical vs. Palliative Treatment 
8.1.3. Prognostic Factors 

8.2. Assessment of Malignant Peritoneal Disease 

8.2.1. Prognostic Factors 
8.2.2. The role of Laparoscopy 
8.2.3. Histological Classification 

8.3. Cytoreductive Surgery: Technique 

8.3.1. Patient Preparation and Positioning 
8.3.2.  Peritonectomy Procedures 
8.3.3.  Criteria of Non-Viability 

8.4. Intraperitoneal Chemotherapy 

8.4.1. Pharmacokinetic Basis 
8.4.2. Modalities of Intraperitoneal Chemotherapy: Indications and Use 
8.4.3. HIPEC Technique 

8.5. Neoplasms of the Cecal Appendix 

8.5.1. Histological Classification 
8.5.2.  Natural History and Staging 
8.5.3. Surgical Treatment 

8.6. Pseudomyxoma Peritoneum 

8.6.1. Definition and Epidemiology 
8.6.2. Histopathological Classification and Prognosis 
8.6.3. Treatment 

8.7. Peritoneal Carcinomatosis due to Colorectal Cancer 

8.7.1. Treatment 
8.7.2. Role of MRI 
8.7.3. Early Diagnosis and Prevention 

8.8. Peritoneal Carcinomatosis due to Gastric Cancer 

8.8.1. Treatment with Radical Intent: Selection 
8.8.2. Palliative Treatment: Intraperitoneal Options 
8.8.3. Prevention 

8.9. Peritoneal Carcinomatosis due to Ovarian Cancer 

8.9.1.  Primary Treatment 
8.9.2. Role of MRI 
8.9.3. Treatment of Peritoneal Recurrence 

8.10. Peritoneal Mesothelioma 

8.10.1. Definition and Epidemiology 
8.10.2. Histopathological Classification and Prognosis 
8.10.3. Treatment 

Module 9. Mesenchymal Tumors Small Intestine Tumors 

9.1. Epidemiology, Diagnosis and Classification of Soft Tissue Sarcomas and Retroperitoneal Sarcomas Role of Biopsy

9.1.1. Epidemiology  
9.1.2. Classification  
9.1.3. Diagnostic Techniques  
9.1.4. Role of Biopsy 

9.2. Principles of Diagnostic Imaging of Mesenchymal Tumors The Role of Radiology in the Evaluation of Response to Treatment

9.2.1. Mesenchymal Tumors: General Information
9.2.2. Types of Soft Tissue Tumors
9.2.3. Soft Tissue Tumors: Diagnostic Approach
9.2.4. Soft Tissue Tumors: in Detail
9.2.5. Retroperitoneal Sarcomas
9.2.6. Mesenchymal Tumors of the Gastrointestinal Tract
9.2.7. GIST (GastroIntestinal Stromal Tumours)  
9.2.8. Role of Radiology in the Response to Treatment and Follow-Up of Non-GIST Soft Tissue Sarcomas 

9.3. Surgical Treatment of Gastrointestinal Stromal Tumors (GIST) Radical Surgery, Minimally Invasive Surgery, Surgery for Recurrence, Surgery for Metastasis 

9.3.1. Incidence and Epidemiology  
9.3.2. Histology and Molecular Biology  
9.3.3. Clinical Features and Diagnostic Approach  
9.3.4. Staging and RISK FACTORS
9.3.5. Treating Locoregional Disease  

9.3.5.1. Radical Surgery  
9.3.5.2. Anatomical Location and Surgical Technique  
9.3.5.3. Minimally Invasive Surgery  
9.3.5.4. Indications for Adjuvant Therapy in Localized Disease

9.3.6. Treatment of Locally Advanced Disease  
9.3.7. Treatment of Residual, Recurrent or Metastatic Disease  
9.3.8. Monitoring 

9.4. Systemic Treatment, Prognosis, and Genotyping of GISTs 

9.4.1. Introduction  
9.4.2. Molecular Biology and Classification  

9.4.2.1. GIST with SDH-Competent Complex and Mutations in KIT or PDGFRA  

9.4.2.1.1. KIT Gene  
9.4.2.1.2. PDGFRA Gene  
9.4.2.1.3. Therapeutic Consequences in Localized and Advanced Disease  

9.4.2.2. GIST without KIT/PDGFRA Mutations and SDH-Competent SDH Complex  

9.4.2.2.1. NF1 Mutations  
9.4.2.2.2. BRAF Mutations  
9.4.2.2.3. NTRK Mutations  
9.4.2.2.4. FGFR Mutations  
9.4.2.2.5. Other Rare Mutations  

9.4.3. GIST with Deficient SDH Complex  
9.4.4. Histopathology of GIST  
9.4.5. Localized Disease and Risk Stratification  

9.5. Retroperitoneal Sarcomas Principles of Systemic and Radiotherapeutic Treatment

9.5.1. Introduction  
9.5.2. Content  
9.5.3. Neoadjuvant/Preoperative Therapy  

9.5.3.1.  Radiotherapy  
9.5.3.2. Chemotherapy  
9.5.3.3. Hyperthermia  

9.5.4. Intraoperative Radiotherapy  
9.5.5. Adjuvant/Postoperative Therapy  

9.5.5.1. Radiotherapy  
9.5.5.2. Chemotherapy  

9.5.6. Expert Recommendations  

9.5.6.1. National Comprehensive Cancer Network (NCCN)  
9.5.6.2. European Society for Medical Oncology (ESMO)   
9.5.6.3. Transatlantic Task Force on Retroperitoneal Sarcomas (TARPSWG)   

9.5.7. Monitoring  

9.6. Surgical Treatment of Retroperitoneal Sarcomas  

9.6.1. Introduction   
9.6.2. Surgery in Retroperitoneal Liposarcoma  

9.6.2.1. Basics of Compartment Surgery  
9.6.2.2. Surgical Technique of Compartment Surgery  

9.6.3. Surgery in Other Retroperitoneal Sarcomas  
9.6.4. Surgical Management of Recurrence   

9.7. Soft Tissue Sarcomas of the Extremities and Thoracic Wall 

9.7.1. Introduction   

9.7.1.1. Classification  
9.7.1.2. Incidence, Location and Risk Factors  

9.7.2. Diagnosis  

9.7.2.1. Local Exploration  
9.7.2.2. Complementary Tests  

9.7.3. Histological Diagnosis  

9.7.3.1. Degrees  
9.7.3.2. Histology   
9.7.3.3. Tumor Staging  

9.7.4. Treatment Management  

9.7.4.1. Localized Disease  

9.7.4.1.1. Surgery  
9.7.4.1.2. Radiotherapy  
9.7.4.1.3. Chemotherapy  
9.7.4.1.4. Isolated Limb Perfusion  

9.7.5. Metastatic Cancer  

9.7.5.1. Monitoring  

9.8. Small Intestine and Mesenteric Tumors Neuroendocrine Tumors of the Gastrointestinal Tract 

9.8.1. Classification  
9.8.2. Adenocarcinoma of the Small Intestine  

9.8.2.1. Pathogenesis, Risk Factors and Predisposing Conditions  
9.8.2.2. Staging and Prognosis  
9.8.2.3. Clinical Characteristics  
9.8.2.4. Diagnosis   
9.8.2.5. Treatment  

9.8.3. Lymphomas  

9.8.3.1. Clinical Characteristics  
9.8.3.2. Diagnosis  

9.8.4. Neuroendocrine Tumors of the Gastrointestinal Tract  

9.8.4.1. Classification and Nomenclature  
9.8.4.2. Incidence and Epidemiology  
9.8.4.3. Anatomy and Pathophysiology  
9.8.4.4. Clinical Presentation  
9.8.4.5. Diagnosis  
9.8.4.6. Staging and Risk Factors  
9.8.4.7. Surgical Treatment  
9.8.4.8. Medical Treatment  
9.8.4.9 Follow-Up  

9.9. Desmoid Fibromatosis Role of Molecular Biology, Radiotherapy, Chemotherapy and “Watch and Wait”

9.9.1. Introduction 
9.9.2. Molecular Biology 
9.9.3. Radiotherapy 
9.9.4. Chemotherapy 
9.9.5. Watch and wait 

9.10. Surgery for Metastatic Disease in Mesenchymal Tumors 

9.10.1. Surgical Treatment of Pulmonary Metastases  
9.10.2. Surgical Treatment of Hepatic Metastases  
9.10.3. Surgical Treatment of Peritoneal Metastases  

9.10.3.1. Role of HIPEC Therapy in Peritoneal Sarcomatosis  

9.10.3.1.1. Peritoneal Sarcomatosis of Uterine Origin  
9.10.3.1.2. Peritoneal Sarcomatosis of Retroperitoneal Origin  
9.10.3.1.3. Peritoneal Sarcomatosis Secondary to GIST

Module 10. Innovation, Research and Development in Digestive Oncologic Surgery 

10.1. Basic Research in Oncological Surgery 

10.1.1. Genomic Introduction 
10.1.2. Introduction to Proteomics 
10.1.3. Introduction to Cytometry 

10.2. Platforms for Testing New Therapies 

10.2.1. Animal Models 
10.2.2. 2D Cellular Models 
10.2.3. 3D Organoid Models 

10.3. Clinical Research in Oncologic Surgery 

10.3.1. Clinical Trial Design 
10.3.2. Sources of Financing 
10.3.3. Introduction to Grant Application Methodology 

10.4. Big Data, Artificial Intelligence and the Use of Neural Networks in Oncology Research 

10.4.1. Introduction to Big Data 
10.4.2. Artificial Intelligence in Oncological Surgery 
10.4.3. Use of Neural Networks in Oncologic Research 

10.5. Techniques and Applications of Fluorescence in Advanced Oncologic Surgery 

10.5.1. Use of Fluorescence in Oncologic Surgery 
10.5.2. Techniques of Use, Doses, Times 
10.5.3. Results 

10.6. Navigation Systems, 3D Models and Intraoperative Virtual Reality in the Approach to Oncologic Disease 

10.6.1. Browsing Systems 
10.6.2. Uses and Application of 3D Models 
10.6.3. Intraoperative Virtual Reality 

10.7. Minimally Invasive Approach in Complex Oncologic Surgery 

10.7.1. Concept of Minimally Invasive Approach and Modalities 
10.7.2. Description of the Different Modalities 
10.7.3. Robotics 

10.8. Intraoperative Ablative and Adjuvant Techniques in Oncologic Surgery 

10.8.1. Intraoperative Ablation Techniques: Mechanism of Action 
10.8.2. Differences, Advantages, and Disadvantages 
10.8.3. Intraoperative Radiotherapy 

10.9. Liquid Biopsy and Circulating DNA as Diagnostic and Prognostic Methods in Advanced Neoplastic Disease 

10.9.1. What is Liquid Biopsy? 
10.9.2. How is an Fluid Biopsy Done? 
10.9.3. Applications of Liquid Biopsy 

10.10. New lines of Oncological Treatment 

10.10.1. Target Therapy in Digestive Oncology and Sarcomas 
10.10.2. Immunotherapy in Digestive Tumors 
10.10.3. CAR-T Therapy

Download all the contents to gain an essential reference guide in the field of Oncologic Digestive Surgery, being useful even after the end of the program”